Yusuf Tamam

Dicle, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Human calprotectin as a novel biomarker in multiple sclerosis: Can it differentiate disease stages?

Human calprotectin as a novel biomarker in multiple sclerosis: Can it differentiate disease stages?

Journal: Medicine

Published: May 26, 2025

Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte Glycoprotein

Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte Glycoprotein

Journal: Balkan medical journal

Published: June 03, 2024

Use of follow-on fingolimod for multiple sclerosis: Analysis of effectiveness and patient reported outcomes in a real-world clinical setting.

Use of follow-on fingolimod for multiple sclerosis: Analysis of effectiveness and patient reported outcomes in a real-world clinical setting.

Journal: Multiple sclerosis and related disorders

Published: May 03, 2023

Relationship between optical coherence tomography angiography and visual evoked potential in patients with multiple sclerosis.

Relationship between optical coherence tomography angiography and visual evoked potential in patients with multiple sclerosis.

Journal: Indian journal of ophthalmology

Published: February 28, 2022

The Effect of Lidocaine on the Experimental Model of Streptozotocin-Induced Alzheimer's Disease.

The Effect of Lidocaine on the Experimental Model of Streptozotocin-Induced Alzheimer's Disease.

Journal: Noro psikiyatri arsivi

Published: January 25, 2022

The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?

The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?

Journal: Multiple sclerosis and related disorders

Published: August 12, 2021

CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis.

CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: November 21, 2020

Adipokines in Multiple Sclerosis Patients with and without Optic Neuritis as the First Clinical Presentation.

Adipokines in Multiple Sclerosis Patients with and without Optic Neuritis as the First Clinical Presentation.

Journal: Immunological investigations

Published: October 16, 2018

Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial.

Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial.

Journal: Multiple sclerosis and related disorders

Published: March 01, 2018

Serum levels of inflammasome pathway factors in clinically isolated syndrome and multiple sclerosis patients: a pilot study.

Serum levels of inflammasome pathway factors in clinically isolated syndrome and multiple sclerosis patients: a pilot study.

Journal: Central-European journal of immunology

Published: December 28, 2017

Testing patient-reported outcome measurement equivalence in multinational clinical trials: An exemplar using the 12-item Multiple Sclerosis Walking Scale.

Testing patient-reported outcome measurement equivalence in multinational clinical trials: An exemplar using the 12-item Multiple Sclerosis Walking Scale.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: April 17, 2017

Investigation of the prognostic value of adipokines in multiple sclerosis.

Investigation of the prognostic value of adipokines in multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: December 29, 2016

Showing 1-12 of 23

Last Updated: 09/26/2026